Advanced Psychiatry of Elgin provides SPRAVATO® ketamine therapy to people suffering from the debilitating symptoms of treatment-resistant mood disorders. By utilizing cutting-edge nasal spray ketamine treatments, the clinic can provide people access to medication that has proven to be effective in over 75 percent of people. As well as TMS therapy, which is often covered by insurance. Conditions they treat include depression, anxiety, and post-traumatic stress disorder.
The wellness center is led by Dr. Fareha N. Malik, a cognizant psychiatrist. She utilizes mindfulness and conscientiousness in her practice alongside other forms of mood disorder therapies. Dr. Malik and the highly-trained staff at Advanced Psychiatry of Elgin are passionate about healing.
The clinic offers comprehensive and individualized plans in a warm and welcoming environment. They hope that by using ketamine therapy, they can give their patients a new lease on life.
S-ketamine (esketamine), sold under the brand name Spravato, is the S-enantiomer of ketamine. The FDA approved it, as a nasal spray, on March 5, 2019, for treatment-resistant depression (depression that has not responded to antidepressant medications).
On August 3, 2020, the FDA also approved Spravato for the treatment of major depressive disorder (MDD) with acute suicidal ideation or behavior.
At Advanced Psychiatry of Elgin, Spravato is self-administered by the patient while being monitored by a specially trained medical assistant at regular intervals.